M
Martine Cools
Researcher at Ghent University Hospital
Publications - 161
Citations - 6136
Martine Cools is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Disorders of sex development & Gonadoblastoma. The author has an hindex of 40, co-authored 145 publications receiving 5077 citations. Previous affiliations of Martine Cools include Ghent University & Erasmus University Rotterdam.
Papers
More filters
Journal ArticleDOI
Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
Martine Cools,Stenvert L. S. Drop,Katja P. Wolffenbuttel,J. Wolter Oosterhuis,Leendert H. J. Looijenga +4 more
TL;DR: A new classification system for patients with DSD is proposed as a tool to refine insight in the prevalence of germ cell tumors in specific diagnostic groups and the correct diagnosis of early neoplastic lesions in this patient population.
Journal ArticleDOI
Horizontal cooperation in logistics : Opportunities and impediments
TL;DR: In this paper, the authors present the results of a large-scale survey on the potential benefits of and impediments for horizontal cooperation in Flanders, finding a reliable party to lead the cooperation and constructing a fair allocation mechanism for the benefits are the impediments that respondents agree with most.
Journal ArticleDOI
Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort
Stefanie Eggers,Simon Sadedin,Jocelyn van den Bergen,Gorjana Robevska,Thomas Ohnesorg,Jacqueline K. Hewitt,Jacqueline K. Hewitt,Luke S. Lambeth,Aurore Bouty,Ingrid M. Knarston,Tiong Yang Tan,Fergus J. Cameron,George A. Werther,John M. Hutson,Michele A O'Connell,Sonia Grover,Sonia Grover,Yves Heloury,Margaret Zacharin,Philip Bergman,Philip Bergman,Chris Kimber,Justin C. Brown,Justin C. Brown,Nathalie Webb,Matthew F. Hunter,Shubha Srinivasan,Angela Titmuss,Charles F. Verge,Charles F. Verge,David Mowat,Grahame H.H. Smith,Grahame H.H. Smith,Janine Smith,Lisa Ewans,Lisa Ewans,Carolyn Shalhoub,Patricia Crock,Christopher T. Cowell,Gary M. Leong,Makato Ono,Antony R Lafferty,Tony Huynh,Uma Visser,Catherine S. Choong,Catherine S. Choong,Fiona Haslam McKenzie,Fiona Haslam McKenzie,Nicholas Pachter,Nicholas Pachter,Elizabeth Thompson,Elizabeth Thompson,Jennifer J Couper,Anne Baxendale,Jozef Gecz,Benjamin J Wheeler,Craig Jefferies,Karen E MacKenzie,Paul L. Hofman,Philippa Carter,Richard I. King,Csilla Krausz,Conny M. A. van Ravenswaaij-Arts,Leendert H. J. Looijenga,Sten L. S. Drop,Stefan Riedl,Stefan Riedl,Martine Cools,A. J. Dawson,Achmad Zulfa Juniarto,Vaman Khadilkar,Anuradha Khadilkar,Vijayalakshmi Bhatia,Vũ Chí Dũng,Irum Atta,Jamal Raza,Nguyen Thi Diem Chi,Tran Kiem Hao,Vincent R. Harley,Peter Koopman,Garry L. Warne,Garry L. Warne,Sultana M.H. Faradz,Alicia Oshlack,Katie L. Ayers,Andrew H. Sinclair +85 more
TL;DR: A massively parallel sequencing targeted DSD gene panel which allows us to sequence all 64 known diagnostic DSD genes and candidate genes simultaneously and expands the understanding of the underlying genetic etiology of DSD.
Journal ArticleDOI
Caring for individuals with a difference of sex development (DSD): a Consensus Statement.
Martine Cools,Anna Nordenström,Ralitsa Robeva,Joanne Hall,Puck Westerveld,Christa E. Flück,Birgit Köhler,Marta Berra,Alexander Springer,Katinka Schweizer,Vickie Pasterski +10 more
TL;DR: This Consensus Statement, developed by a European multidisciplinary group of experts, including patient representatives, summarizes evidence-based and experience-based recommendations for lifelong care and data collection in individuals with a DSD across ages and highlights clinical research priorities.
Journal ArticleDOI
Tumor risk in disorders of sex development (DSD).
Leendert H. J. Looijenga,Remko Hersmus,J. Wolter Oosterhuis,Martine Cools,Stenvert L. S. Drop,Katja P. Wolffenbuttel +5 more
TL;DR: In this paper, it is proposed that morphological and histological evaluation of gonadal tissue, in combination with OCT3/4 and TSPY double immunohistochemistry and clinical parameters, is most informative in estimating the risk for germ-cell tumor development in the individual patient, and might in future be used to develop a decision tree for optimal management of patients with DSD.